A detailed history of Polar Capital Holdings PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 324,176 shares of ABBV stock, worth $53.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
324,176
Previous 361,808 10.4%
Holding current value
$53.8 Million
Previous $56.1 Million 5.28%
% of portfolio
0.37%
Previous 0.4%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $6.01 Million - $6.85 Million
-37,632 Reduced 10.4%
324,176 $59 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $696,806 - $784,768
-5,064 Reduced 1.38%
361,808 $56.1 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $1.07 Million - $1.24 Million
8,000 Added 2.23%
366,872 $54.7 Million
Q2 2023

Dec 13, 2023

BUY
$132.51 - $164.9 $4.95 Million - $6.16 Million
37,368 Added 11.62%
358,872 $48.4 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $4.95 Million - $6.16 Million
37,368 Added 11.62%
358,872 $48.4 Million
Q1 2023

Dec 13, 2023

SELL
$144.61 - $166.54 $6.56 Million - $7.56 Million
-45,368 Reduced 12.37%
321,504 $51.2 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $1.04 Million - $1.19 Million
7,167 Added 2.28%
321,504 $51.2 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $1.96 Million - $2.35 Million
-14,173 Reduced 4.31%
314,337 $50.8 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $6.14 Million - $7.04 Million
45,718 Added 16.17%
328,510 $44.1 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $32.5 Million - $41.4 Million
236,416 Added 509.78%
282,792 $43.3 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $585,625 - $664,773
5,504 Added 13.47%
46,376 $5 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $4.3 Million - $4.79 Million
40,872 New
40,872 $4.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.